In an interview with Myeloma Patients Europe, Michael Hudecek explains the H2020 CARAMBA project and its role for Multiple Myeloma patients. Next to general information on CAR-T treatment and the innovative SLAMF7 CAR-T cells, he gives deeper insights into the planned PhaseI/II clinical trial and how patients may be involved. Video is coming soon

Share This